PROVEO is a Division of Cerbios-Pharma providing complete and efficient solutions to the market for the process development and manufacture of antibody drug conjugates (ADCs).

The Division is based on Cerbios expertise in bioconjugation and cytotoxic drug-linker payload, supported by the exclusive know-how and specific competencies of its partners. AGC Biologics is specialized in monoclonal antibody production and  Oncotec provides aseptic fill and lyophilization of the ADC drug product, supply chain, and secondary packaging through to ready-to-deliver final drug product.